Literature DB >> 11418695

T cell epitope mapping of the Smith antigen reveals that highly conserved Smith antigen motifs are the dominant target of T cell immunity in systemic lupus erythematosus.

B L Talken1, K R Schäfermeyer, C W Bailey, D R Lee, R W Hoffman.   

Abstract

B cell and T cell immunity to the Smith Ag (Sm) is a characteristic feature of systemic lupus erythematosus (SLE). We have shown that T cell immunity against Sm can be detected in SLE patients, and that T and B cell immunity against Sm are linked in vivo. TCR usage by Sm-reactive T cells is highly restricted and characteristic of an Ag-driven immune response. Sm is a well-characterized complex Ag consisting of proteins B1, B2, D1, D2, D3, E, F, and G. A unique feature of all Sm proteins is the presence of homologous motifs, Sm motif 1 and Sm motif 2. We used limiting dilution cloning and synthetic peptide Ags to characterize the human T cell immune response against Sm in seven SLE patients. We sought to determine the precise antigenic peptides recognized, the common features of antigenic structure recognized, and the evolution of the T cell response against Sm. We found there was a highly restricted set of Sm self-peptides recognized by T cells, with three epitopes on Sm-B and two epitopes on Sm-D. We found that T cell immunity against Sm-B and Sm-D was encoded within the highly conserved Sm motif 1 and Sm motif 2, and that immunity against these epitopes appeared stable. The present study supports the concept that T cell immunity to Sm is an Ag-driven immune response directed against a highly restricted set of self-peptides, encoded within Sm motif 1 and Sm motif 2, that is shared among all Sm proteins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11418695     DOI: 10.4049/jimmunol.167.1.562

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Epitope mapping of the U1 small nuclear ribonucleoprotein particle in patients with systemic lupus erythematosus and mixed connective tissue disease.

Authors:  J A Somarelli; A Mesa; R Rodriguez; R Avellan; L Martinez; Y J Zang; E L Greidinger; R J Herrera
Journal:  Lupus       Date:  2011-03       Impact factor: 2.911

Review 2.  Dendritic cells in systemic lupus erythematosus.

Authors:  Heather M Seitz; Glenn K Matsushima
Journal:  Int Rev Immunol       Date:  2010-04       Impact factor: 5.311

3.  HLA-DR3 restricted T cell epitope mimicry in induction of autoimmune response to lupus-associated antigen SmD.

Authors:  Umesh S Deshmukh; Davis L Sim; Chao Dai; Carol J Kannapell; Felicia Gaskin; Govindarajan Rajagopalan; Chella S David; Shu Man Fu
Journal:  J Autoimmun       Date:  2011-08-24       Impact factor: 7.094

4.  CD4+ T cells target epitopes residing within the RNA-binding domain of the U1-70-kDa small nuclear ribonucleoprotein autoantigen and have restricted TCR diversity in an HLA-DR4-transgenic murine model of mixed connective tissue disease.

Authors:  Eric L Greidinger; Yun Juan Zang; Kimberly Jaimes; Laisel Martinez; Mehdi Nassiri; Robert W Hoffman
Journal:  J Immunol       Date:  2008-06-15       Impact factor: 5.422

5.  Most nuclear systemic autoantigens are extremely disordered proteins: implications for the etiology of systemic autoimmunity.

Authors:  Philip L Carl; Brenda R S Temple; Philip L Cohen
Journal:  Arthritis Res Ther       Date:  2005-10-06       Impact factor: 5.156

6.  Immunoregulatory soluble CTLA-4 modifies effector T-cell responses in systemic lupus erythematosus.

Authors:  Lekh N Dahal; Neil Basu; Hazem Youssef; Rahul C Khanolkar; Robert N Barker; Lars P Erwig; Frank J Ward
Journal:  Arthritis Res Ther       Date:  2016-08-04       Impact factor: 5.156

7.  Inter-molecular epitope spreading does not lead to extension of autoimmunity beyond target tissue in autoimmune glomerulonephritis.

Authors:  April Ross; Jean Wu; Colin Carlock; William Glass; Ya-Huan Lou
Journal:  PLoS One       Date:  2018-08-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.